Fibralign Announces CE Mark Approval for BioBridge
/
DateSep 14 2020
Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge® Collagen Matrix. Read More →